Edith Uetz‐von Allmen

Author

Also Known As

Al., Edith Uetz-Von Allmen Et, Al., Uetz-Von Allmen Edith Et, EDITH VON ALLMEN, Edith C. von Allmen, Edith Uetz-von Allmen, Edith Uetz‐von Allmen, Edith von Allmen

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Biotechnology Institute Thurgau University of Konstanz University of Bern University of St.Gallen ETH Zurich

About

Edith Uetz‐von Allmen is an author at Biotechnology Institute Thurgau specializing in medicine, immunology, and biomedical engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	517
2	Biomedical Engineering	3	3	286
3	Engineering	2	2	162
4	Allergy	1	1	75
5	Cell Biology	1	1	38

Edith Uetz‐von Allmen

Publications

779

Citations

H-Index

Page 1

	Year	Citations
Encapsulation of proteins and peptides into biodegradable poly(d,l-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells Ying Waeckerle‐Men, Edith Uetz‐von Allmen, Bruno Gander, Vaccine Cell-based Drug DeliveryHuman Dendritic CellsMedicinePeptide EngineeringImmunology	2005	124
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma Ying Waeckerle‐Men, Edith Uetz‐von Allmen, M. Fopp, Cancer Immunology Immunotherapy Cancer ImmunosurveillanceImmunologyHormone-refractory Prostate CarcinomaProstatic DiseaseImmunotherapy	2006	118
CCR7: Roles in cancer cell dissemination, migration and metastasis formation Daniel F. Legler, Edith Uetz‐von Allmen, Mark A. Hauser The International Journal of Biochemistry & Cell Biology	2014	87
Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy Ying Waeckerle‐Men, Elke Scandella, Edith Uetz‐von Allmen, Journal of Immunological Methods Cell-based Drug DeliveryEngineeringImmunoengineeringImmunologyTherapeutic Vaccine	2004	84
The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles Stefan Fischer, Edith Uetz‐von Allmen, Ying Waeckerle‐Men, Biomaterials NanomedicineEngineeringGranulocyteImmunologyNano-drug Delivery	2006	78
Detection, immunoabsorption, and inhibition of cytotoxic activity of anti‐αGal antibodies using newly developed substances with synthetic Gal α1–3Gal disaccharide epitopes Robert Rieben, Edith Uetz‐von Allmen, Elena Korchagina, Xenotransplantation ImmunohematologyAnti‐αgal IgmGlycobiologyImmunologyImmune Regulation	1995	75
V domain of RAGE interacts with AGEs on prostate carcinoma cells Edith Uetz‐von Allmen, Michael Koch, G. Fritz, The Prostate	2008	55
Loss of GM130 in breast cancer cells and its effects on cell migration, invasion and polarity Francesco Baschieri, Edith Uetz‐von Allmen, Daniel F. Legler, Cell Cycle Breast OncologyGm130 DepletionCancer BiologyTumor BiologySignaling Pathway	2015	38
IN VITRO EVALUATION OF THE EFFICACY AND BIOCOMPATIBILITY OF NEW, SYNTHETIC ABO IMMUNOABSORBENTS Robert Rieben, Elena Korchagina, Edith Uetz‐von Allmen, Transplantation	1995	38
Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7 Astrid Sissel Jørgensen, Olav Larsen, Edith Uetz‐von Allmen, Frontiers in Immunology	2019	29

Page 1